Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

Figure 11

Fitting the model to individual trajectories in the case of therapy 2: simulated output (with the parameters obtained from fitting the model to the specific trajectory (), simulated output with nominal parameters (), and measured output.)

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)